Single-Use Bioreactor Market is Estimated to Witness High Growth Owing to Increasing Adoption in Biopharmaceutical Manufacturing
![]() |
Single-Use Bioreactor Market |
Single-use bioreactors are advanced bioreactors designed for single-use
applications in biopharmaceutical manufacturing. They offer various advantages
such as reduced risk of cross-contamination, lower capital investment, lower
cleaning and validation costs, and improved process flexibility. Single-use
bioreactors find wide applications in the production of monoclonal antibodies,
vaccines, stem cells, insect cells, and plant cell culture. They help minimize
operation costs and time to market by streamlining cell culture processes. The
global single-use bioreactor market is estimated to be valued at US$ 1337.67 Mn
in 2023 and is expected to exhibit a CAGR of 15.% over the forecast period 2023
to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Dynamics:
The increasing adoption of single-use bioreactors in biopharmaceutical
manufacturing is a key driver fueling the market growth. Rising demand for
biologics and growing biopharmaceutical industry have necessitated improved
manufacturing technologies like single-use bioreactors. Their advantages over
traditional stainless steel bioreactors such as lower capital costs, reduced
operation costs, easy installation and process optimization are boosting their
adoption rates. However, challenges pertaining to extractable and leachables
from single-use components need to be addressed carefully for ensuring safety
of biopharmaceutical products. Ongoing technological advancements in single-use
bioreactor systems focusing on safety, automation, and connectivity are
estimated to offer lucrative opportunities over the forecast period.
SWOT Analysis
Strength: Single-use bioreactors offer increased cost savings compared to
traditional stainless steel bioreactors. They minimize capital expenditure and
operational costs as there is no requirement of cleaning and sterilization
after each batch production. Single-use bioreactors can be easily installed and
replaced, thereby reducing process downtime.
Weakness: Limited reusability of single-use components leads to increased
material costs over time. Additionally, lack of technical support for custom
configurations is another drawback.
Opportunity: Growing need for cost-effective and flexible manufacturing processes
across industries like pharmaceuticals and biopharmaceuticals is fueling demand
for single-use bioreactors. Increasing investments in cell culture-based
research is also opening up opportunities.
Threats: Stringent regulations pertaining to the material composition and
leachables may limit the application scope. Risk of product contamination due
to product contact remains a challenge.
Key Takeaways
The global Single-Use
Bioreactor Market Demand is expected to witness high growth over the
forecast period 2023 to 2030 on account of rapid expansion of the
biopharmaceutical sector. Regionally, North America dominated the market in
2023 with over 35% share owing to robust government support and presence of key
players. Growth rates are estimated higher in Asia Pacific as countries like
China and India emerge as major hubs for biopharma companies to outsource
manufacturing.
Key players operating in the single-use bioreactor market are Sartorius AG,
OmniBRx Biotechnologies, Merck KgaA, Solaris Biotechnology Srl, Eppendorf AG,
Distek Inc., Celltainer Biotech BV, ABEC Inc., Thermo Fisher Scientific, and
Danaher Corporation (Pall Corporation), among others. These companies are
focusing on capacity expansion and new product launches to consolidate their
market position. For instance, Sartorius AG recently inaugurated a new
single-use system manufacturing facility in Maine to support significant
capacity increases for the North American market.
The global single-use bioreactor market is expected to witness high growth over
the forecast period 2023 to 2030 on account of rapid expansion of the
biopharmaceutical sector. Regionally, North America dominated the market in
2023 with over 35% share owing to robust government support and presence of key
players. Growth rates are estimated higher in Asia Pacific as countries like
China and India emerge as major hubs for biopharma companies to outsource
manufacturing.
Get more insights on this topic: https://www.pressreleasebulletin.com/single-use-bioreactor-market-growth-demand-and-overview/
Comments
Post a Comment